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Abstract 
Background: Despite the uptake of parasitological testing into policy and practice, appropriate prescription of 
anti-malarials and artemisinin-based combination therapy (ACT) in accordance with test results is variable. This study 
describes a National Malaria Control Programme-led capacity building intervention which was implemented in 10 
States of Nigeria. Using the experience of Niger State, this study assessed the effect on malaria diagnosis and prescrip-
tion practices among febrile under-fives in rural health facilities.
Methods: The multicomponent capacity building intervention consisted of revised case management manuals; cas-
cade training from national to state level carried out at the local government area (LGA) level; and on the job capacity 
development through supportive supervision. The evaluation was conducted in 28, principally government-owned, 
health facilities in two rural LGAs of Niger State, one in which the intervention case management of malaria was 
implemented and the other acted as a comparison area with no implementation of the intervention. Three outcomes 
were considered in the context of rapid diagnostic testing (RDT) for malaria which were: the prevalence of RDT test-
ing in febrile children; appropriate treatment of RDT-positive children; and appropriate treatment of RDT-negative 
children. Outcomes were compared post-intervention between intervention and comparison areas using multivariate 
logistic regression.
Results: The intervention did not improve appropriate management of under-fives in intervention facilities above 
that seen for under-fives in comparison facilities. Appropriate treatment with artemisinin-based combinations of 
RDT-positive and RDT-negative under-fives was equally high in both areas. However, appropriate treatment of RDT-
negative children, when defined as receipt of no ACT or any other anti-malarials, was better in comparison areas. In 
both areas, a small number of RDT-positives were not given ACT, but prescribed an alternative anti-malarial, including 
artesunate monotherapy. Among RDT-negatives, no under-fives were prescribed artesunate as monotherapy.
Conclusion: In a context of significant stock-outs of both ACT medicines and RDTs, under-fives were not more 
appropriately managed in intervention than comparison areas. The malaria case management intervention imple-
mented through cascade training reached only approximately half of health workers managing febrile under-fives in 
this setting. Implementation studies on models of cascade training are needed to define what works in what context.
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Background
In 2010, the World Health Organization (WHO) 
updated the Guidelines for Malaria Diagnosis and 
Treatment. The policy of presumptive treatment for 
malaria in children with no obvious alternative cause 
of fever was replaced by a recommendation that, where 
possible, parasitological confirmation of infection be 
established before treatment, and anti-malarial treat-
ment be restricted to parasite-positive patients [1].
By 2011, 37 African countries including Nigeria had 
a malaria parasite-based diagnosis for treatment for all 
age groups [2–5]. Following the introduction of rapid 
diagnostic tests (RDTs) for malaria, in many African 
countries there has been a positive trend in the propor-
tion of suspected malaria cases receiving a parasitologi-
cal test among patients attending the public sector [6]. 
Among febrile children under 5 years of age surveyed 
during nationally representative household surveys in 
the WHO African Region, the prevalence of testing in 
the public sector was 59% in 2017 [7], and 14% in Nige-
ria [8].
In 2010, prior to the inception of this study, preva-
lence of testing was lower still, at about 30% for the 
WHO African Region as a whole and 5% in Nigeria [7]. 
However, despite the uptake of parasitological test-
ing into policy and practice, appropriate prescription 
of anti-malarials and artemisinin-based combination 
therapy (ACT) in accordance with test results is vari-
able [9]. Studies have shown variability in adherence 
to current guidelines for malaria treatment based on 
confirmed diagnosis, in particular in the management 
of test-negative patients [9, 10]. Parasitological diag-
nosis is just one of the processes required for a child 
to receive and benefit from appropriate and effective 
treatment. The other processes according to the Nige-
rian National Malaria Treatment guidelines include 
correct diagnosis, prescription of the most appropriate 
drug, dispensing of the correct amount of the drugs and 
clear explanation by the clinician of the diagnosis and 
dosing regimen. Furthermore, the guidelines emphasize 
the need for caregiver’s understanding and ability to 
recall messages relating to adherence to correct dosing 
regimen [1, 5].
The malaria case management capacity building 
programme of the Nigerian National Malaria Con-
trol Programme (NMCP) took place across a quarter 
of the States of Nigeria, and this study assessed the 
effectiveness of the programme on malaria diagnosis 
and prescription practices among febrile under-fives 
attending rural health facilities in one of the ten imple-
menting States, Niger State.
Methods
Intervention description
Between 2008 and 2015, the Nigerian National Malaria 
Control Programme was supported to conduct a phased 
capacity building programme on malaria case man-
agement in 10 of the 37 States of Nigeria. These States 
included: Lagos, Kano, Anambra, Katsina, Niger, Ogun, 
Jigawa, Enugu, Kaduna and Yobe. Training materials were 
developed and a system of cascade training from State to 
local government area (LGA) level (i.e. district equivalent 
level) was implemented for health care workers.
The malaria case management capacity building inter-
vention consisted of: (1) revised case management manu-
als including adult learning exercises; (2) cascade training 
where national level facilitators, including content and 
adult learning experts, supported the State to train State 
level facilitators or trainers, who then conducted 3 day 
training sessions; and (3) on the job capacity develop-
ment through integrated supportive supervision, with the 
State level facilitators/trainers acting as supervisors.
Study area and population
This study was carried out from October 2011 to March 
2013, in two local government areas, Katcha and Gbako 
of Niger State. Niger State is located in the North Cen-
tral geopolitical zone of Nigeria and has a total of 25 local 
government areas, with an overall population of approxi-
mately 4.3 million people. The State has high infant and 
under-five mortality rates of 85 and 106 per 1000 live 
births, respectively, compared with the national average 
of 75 and 106 per 1000, respectively [3, 11]. Like many 
other parts of Nigeria, malaria is endemic in Niger State, 
with year-round transmission. In 2010, 45% of febrile 
under-fives tested in the North Central zone were RDT-
positive [12] and malaria constituted the highest propor-
tion of childhood febrile illnesses presenting to health 
facilities [3, 11].
At the time of this study, there were 1323 primary 
health care facilities (PHCs), 18 secondary health facili-
ties and two tertiary health facilities in Niger State. Ser-
vices, including diagnostics and prescribed treatment 
were provided free of charge by primary health care 
facilities to pregnant women and children under-5 years 
of age. In addition to the government owned health care 
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facilities, there were also 446 registered private health 
facilities (hospitals, clinics, maternities, and laboratories) 
and 1200 licensed Patent Medicine Vendors.
Study design and sampling procedure
The two LGAs were purposively selected on the basis of 
similarity in socio-economic characteristics and the ratio 
of public to private sector facilities. Sample size calcula-
tion was based on the proportion of under-fives receiving 
appropriate treatment for febrile illness (i.e. proportion of 
febrile children treated for malaria or tested for malaria 
and treated if positive) estimated at 10% in the compari-
son LGA. Assuming a coefficient of variation k = 0.4, and 
recruitment of 30 under-fives per facility, a minimum of 
28 health facilities (14 per LGA) were required in order 
to detect an absolute difference in appropriate treatment 
prevalence between LGAs of 10%, at a power of 80%, and 
a 5% level of significance (two-sided).
Two stage stratified sampling strategy was used. In 
the first stage, a full list of all public and private facili-
ties in Katcha and Gbako LGAs was compiled and they 
were classified as public or private and then into second-
ary or primary health facilities. Health facilities were 
selected proportional to the total number of facilities in 
each LGA. In total 28 facilities were selected, 14 in each 
LGA. In the second stage 840 febrile under-fives, 30 per 
facility, were selected from included health facilities. 
Recruitment of children from facilities continued over 
subsequent data collection visit days until required sam-
ple sizes were achieved.
Data collection
Surveys were undertaken in Katcha and in Gbako 1 year 
after implementation of the case management train-
ing programme. All health workers involved in man-
agement of febrile under-fives on the day of the survey 
were invited to take part, and following consent, data on 
demographic characteristics of these staff were collected 
from the participating health workers and the health 
facility staff person in charge, using a structured ques-
tionnaire. Characteristics of the health facility were col-
lected using a structured questionnaire and health facility 
stock records were consulted to record availability of 
supplies and equipment necessary for malaria diagnosis 
and treatment on the day of the survey. All health facility 
attendees aged under-5 years presenting with fever or a 
history of fever on each day of the survey were invited to 
take part, and following provision of informed consent, 
participant characteristics for presenting under-fives and 
their accompanying caregiver were collected and all con-
sultation processes observed and recorded using a struc-
tured checklist.
Statistical methods
Data were collected using paper questionnaires and 
subsequently double-entered using EpiData version 3.1 
(EpiData Association, Odense, Denmark). Data were 
analysed using STATA version 13.0 (STATA Corpora-
tion, College Station, Texas). Sample weights for observa-
tions were estimated as the reciprocal of the probability 
of selection of each health facility for analyses conducted 
at the health facility level. Additionally, for analyses con-
ducted at the individual under-five patient level, sample 
weights were estimated based on the product of the sam-
pling weights of each selected health facility and those of 
individual patients. The probability of selection of indi-
vidual under-five patients within each study health facil-
ity was calculated as 30/mean outpatient attendance for 
2010. Descriptive and logistic regression analyses were 
carried out using svy commands.
Due to the change in national guidelines for malaria 
diagnosis and the introduction of confirmatory parasi-
tology during the implementation of this intervention, 
the original primary outcome of appropriate treatment 
defined as febrile children being presumptively treated 
for malaria or tested and treated if positive, was no longer 
considered appropriate. Alternative outcomes of the 
prevalence of RDT use among febrile under-fives, and 
appropriate management of RDT-positives and RDT-
negatives were generated [13]. Appropriate management 
was defined as prescription of artemether–lumefan-
trine (AL) or artesunate–amodiaquine (ASAQ) to RDT-
positive under-fives and no AL or ASAQ prescribed to 
RDT-negative under-fives. As description of the sample 
showed that many of the RDT-negative under-fives who 
were not receiving AL or ASAQ were receiving another 
anti-malarial, appropriate management of RDT-negative 
was also defined as those RDT-negative under-fives who 
were not prescribed any anti-malarial.
Comparison of outcomes of clinical malaria diagnosis 
with rapid diagnostic tests and appropriate management 
of RDT-positive or RDT–negative under-fives was made 
between intervention and comparison areas in 2013, 
following 1 year of implementation of the intervention. 
Facilities and staff in the intervention LGA received the 
package of interventions included in the NMCP’s capac-
ity development programme, while the comparison LGA 
received none of the specified components and experi-
enced only Federal level initiatives (including changes in 
national policy such as the adoption of the WHO guide-
lines for the introduction of confirmatory parasitology).
Univariate logistic regression analyses calculated odds 
ratios (ORs) and confidence intervals (CIs) compar-
ing the odds of these outcomes among under-fives from 
facilities in intervention and comparison LGAs. In mul-
tivariate logistic regression analyses, these associations 
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were investigated controlling for the following a priori 
defined potential confounders: age and gender of the 
child; gender and education level of the carer; age and 
gender of the health worker; as well as RDT availability 
and either AL or ASAQ availability from health facility 
stock records [14].
Ethics
Approval for the study was obtained from the Ethics 
Committees of the Niger State Ministry of Health, the 
University of Ibadan/University College Hospital Ethi-
cal Review Committee and the Ethics Committee of the 
London School of Tropical Medicine and Hygiene, UK.
Results
Summary of NMCP capacity development programme 
implementation in Niger State
The implementation of this programme in Niger State 
began in 2011 at which time surveys with health facil-
ity staff caring for febrile under-fives showed that 27% of 
health workers in intervention area health facilities had 
reported recent malaria training (in the 6 months before 
the survey), while 16% had reported recent training in the 
integrated management of childhood illness (IMCI). Sim-
ilar levels of training were reported by staff from facilities 
in the comparison area- 29% for recent malaria training 
and 23% for recent IMCI training.
By 2013, all 14 facilities in the intervention LGA 
reported that at least one staff member had attended 
malaria training, while 13 of the 14 had done so for IMCI 
training. This contrasted to facilities in the comparison 
LGA where 12 of 14 facilities reported that at least one 
staff member had attended malaria training, but 7 of the 
14 facilities reported that none of the staff interviewed 
had recently attended IMCI training. Table  2 shows 
that a higher proportion (54% versus 34%; p = 0.09) of 
health workers from health facilities in the interven-
tion LGA reported recent malaria training. In addition, 
significantly more health workers from facilities in the 
intervention LGA reported attending IMCI training 
in the last 6 months (45%), in comparison to 20% from 
facilities in the comparison LGA. These results suggest 
that although the training component of the programme 
reached facilities, cascade training did not fully reach 
all staff members within intervention facilities. Further-
more, Table 1 shows that in 2013 similar mean numbers 
of supervision visits were recorded between intervention 
and comparison LGAs, suggesting that this component 
of the capacity development programme did not result in 
more frequent supervision visits in intervention LGAs.
Description of sample
A total of 28 health facilities were sampled, 14 in each 
LGA. The large majority were government-owned in 
both LGAs, with only 3% and 8% of included facilities 
from the private sector (Table 1). Facilities in both LGAs 
had similar catchment sizes.
In total, 171 health workers across these 28 health facil-
ities were interviewed and observed during consultations 
with febrile under-fives during the period of data collec-
tion, with 65% of these health workers based in interven-
tion facilities. About 60% of health workers in selected 
facilities from both LGAs were male, and about 95% 
from the Nupe ethnic group. Health workers from facili-
ties in both LGAs had a mean age of about 35 years, and 
about 70% of health workers had worked at that facility 
for at least 3 years. The majority of staff managing febrile 
under-fives in this setting were Community Health Offic-
ers (CHO) and community health extension workers 
(CHEWs) (or junior community health extension workers 
(JCHEWs)), with fewer than 7% of staff managing under-
fives in either LGA defined as clinically trained (Table 2).
In total, 840 febrile under-fives were recruited, 420 
from facilities in the intervention LGA and likewise in 
the comparison LGA. Under-fives in both areas were 
similar in age, with a mean age of 1.9 years, and similar 
proportions of boys and girls were recruited. Fewer than 
1% of children recruited were covered by the National 
Table 1 Health facility characteristics by LGA
LGA local government area, CI confidence intervals, SD standard deviation
Intervention N = 14 Comparison N = 14 p-value
N % 95% CI n % 95% CI
Facility ownership
 Government 12 97.2 86.4, 99.5 13 92.4 54.1, 99.2
 Private 2 2.8 0.5, 13.6 1 7.6 0.8, 45.9
Mean SD Mean SD
Number of supervision visits in last 
6 months (mean)
2.94 0.51 3.08 1.14 0.91
Catchment area size (mean) 5225 1416 4042 568 0.44
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Health Insurance Scheme. The carers accompanying 
the under-fives were principally female, the majority the 
child’s mother. Almost half of carers reported no formal 
education, and between 22% and 31% reported Islamic 
education (Table 3).
Stock availability
Over the study period, facilities were visited on aver-
age 25 times (range 11–32), and stock availability 
was assessed. On the days of visits, stock availabil-
ity of RDTs and recommended ACT medicines (AL 
and ASAQ) were low in facilities from both LGAs. In 
total, 43% and 15% of included facilities in interven-
tion and comparison LGAs respectively, reported 
that they had neither AL nor ASAQ available for 10% 
of the visit days. Stock-out problems for these ACT 
medicines in the intervention facilities appeared espe-
cially binary, with half of facilities reporting no stock 
on any of the visit days, and the other half report-
ing availability for over 80% of visit days. On average, 
over all visit days, AL or ASAQ were only available for 
about 50% of visit days in both intervention and com-
parison facilities but, as described above, this was not 
evenly distributed between all facilities, in particular 
for those located in the intervention LGA. Problems 
with RDT stock-outs were also recorded for facilities 
in both LGAs with 24% and 46% of facilities in inter-
vention and comparison LGAs respectively reporting 
stock outs of RDTs at every visit day. On average, over 
all visit days, RDTs were available during 67% of visit 
Table 2 Health worker characteristics by LGA
LGA local government area, CI confidence intervals, SD standard deviation, CHO Community Health Officers, CHEW community health extension workers, JCHEW junior 
community health extension workers, IMCI integrated management of childhood illness
Intervention N = 111 Comparison N = 60 p value
N % 95% CI n % 95% CI
Sex (n = 170) 0.784
 Male 70 61.1 42.5, 76.9 35 57.3 34.2, 77.7
 Female 40 38.9 23.1, 57.5 25 42.7 22.4, 65.8
Ethnic group (n = 171) 0.433
 Nupe 105 94.6 78.9, 98.8 59 98.2 88.7, 99.7
 Hausa 1 1.0 0.1, 7.2 0 0
 Other 5 4.4 1.1, 15.8 1 1.8 0.3, 11.3
Highest qualification of health worker (n = 167) 0.191
 Physician 2 2.1 0.6, 6.7 0
 Registered nurse 4 4.2 1.6, 10.6 1 1.8 0.3, 11.9
 Registered midwife 0 1 1.8 0.2, 15.0
 Medical assistant 1 1.0 0.1, 7.8 0
 Nursing assistant 0 0
 Laboratory technician 6 5.4 2.1, 13.4 0
 Ward assistant 6 5.4 1.6, 16.4 1 1.8 0.3, 10.9
 CHO 7 5.6 2.0, 14.8 2 3.6 1.0, 11.8
 CHEW 24 21.7 12.9, 34.2 19 32.6 20.6, 47.5
 JCHEW 29 29.6 19.1, 42.7 14 23.7 15.9, 33.7
 Other 32 24.9 14.6, 39.1 21 34.7 23.2, 48.4
Clinical training (n = 167)
 Clinically trained 6 6.3 2.8, 13.7 2 3.6 0.9, 13.4 0.446
How long worked at facility (n = 171) 0.823
 < 1 year 13 10.2 7.0, 14.5 5 7.3 2.4, 20.6
 1–3 years 22 21.4 10.3, 39.1 12 19.7 8.4, 39.6
 > 3 years 76 68.5 52.1, 81.2 43 73.0 55.9, 85.2
IMCI training (n = 171) 49 44.5 32.4, 57.3 12 19.7 9.0, 37.9 0.020
Malaria training (n = 171) 59 54.1 42.2, 65.5 21 34.1 17.4, 56.0 0.090
Mean SD Mean SD
Mean health worker age (years) 
(n = 166)
35.6 1.04 34.8 1.26 0.664
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days in facilities from the intervention LGA, and dur-
ing 42% of visits in facilities from the comparison LGA 
(p = 0.136) (Table 4).
RDT testing and appropriate treatment for malaria 
among under-fives
A higher proportion of febrile under-fives were tested 
with an RDT in facilities from the intervention LGA (56% 
vs. 36%), but these differences and the effect of the inter-
vention on RDT testing were not statistically significant 
Table 3 Child and carer characteristics by LGA
LGA local government area, CI confidence intervals’, SD standard deviation
Intervention N = 420 Comparison N = 420 p-value
N % 95% CI n % 95% CI
Sex of carer (n = 840) 0.379
 Male 143 31.7 22.0, 43.4 115 24.9 14.7, 38.9
 Female 277 68.3 56.6, 78.0 305 75.1 61.1, 85.3
Relationship to child (n = 833) 0.146
 Mother 265 63.4 52.1, 73.5 295 73.3 59.3, 83.8
 Father 117 24.2 15.8, 35.2 102 22.5 12.4, 37.4
 Relative 32 10.9 5.9, 19.4 15 3.9 1.9, 7.7
 Other 5 1.4 0.5, 4.1 2 0.3 0.1, 1.6
Carer education (n = 838) 0.038
 None 169 47.1 30.4, 64.4 216 57.9 36.8, 76.4
 Primary 24 4.9 2.3, 10.0 27 6.8 3.8, 12.0
 Middle/junior 10 3.3 1.7, 6.6 3 0.8 0.3, 2.5
 Secondary 70 18.6 11.3, 29.2 11 3.0 1.5, 5.9
 Teritary 27 4.3 2.2, 8.4 1 0.2 0.0, 1.9
 Islamic 120 21.7 10.8, 38.8 160 31.3 14.9, 54.2
Sex of child (n = 834) 0.990
 Male 229 55.2 48.1, 62.0 233 55.2 48.0, 62.1
 Female 189 44.8 38.0, 51.9 183 44.8 37.9, 52.0
Health insurance (n = 783) 3 0.9 0.1, 5.4 5 1.0 0.2, 5.0 0.956
Mean SD Mean SD
Mean age child (years) n = 835 1.89 0.15 1.87 0.10 0.994
Mean age carer (years) (n = 464) 29.3 0.42 27.0 1.31 0.107
Table 4 Stock of essential diagnostics and medicines on the days of the survey by LGA
LGA local government area, CI confidence intervals, SD standard deviation, ASAQ artesunate amodiaquine, AL arthemeter–lumefantrine, RDT rapid diagnostic tests
Katcha N = 14 95% CI Gbako N = 14 95% CI p-value
n % n %
Proportion of facilities where neither AL nor ASAQ were available on any of the days the facility was visited
7 43.3 17.7, 73.1 0 0.031
Proportion of facilities where neither AL nor ASAQ was available for < 10% of the days the facility was visited
7 43.3 17.7, 73.1 2 15.2 0.8, 45.9 0.166
Proportion of facilities where RDTs were not available on any of the days the facility was visited
3 24.3 6.8, 58.6 6 45.6 19.6, 74.3 0.186
Mean SD Mean SD
Mean % daily availability of ASAQ 41 14.5 25 8.1 0.337
Mean % daily availability of AL 56 14.3 47 8.9 0.594
Mean % daily availability of ASAQ or AL 56 14.3 50 8.2 0.730
Mean % daily availability of RDTs 67 11.5 42 11.8 0.136
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(adjusted odds ratio (AOR) = 1.41; 95% confidence inter-
val (CI) 0.30, 6.52) (Table  5). Appropriate management 
of RDT-positive under-fives was high in both areas, 
with 85% and 90% of RDT-positive under-fives receiv-
ing AL or ASAQ in comparison and intervention LGAs, 
respectively. Multivariate models indicate no difference 
between the areas (AOR = 1.91; 95% CI 0.36, 10.04) 
(Table 5).
Appropriate management of RDT-negative under-
fives was also high in both areas. In total 96% and 89% of 
RDT-negative under-fives did not receive AL or ASAQ in 
comparison and intervention LGAs, respectively, and no 
effect of the intervention on this outcome was detected 
(AOR = 0.68; 95% CI 0.11, 4.36). However, Fig.  1 shows 
that, in the intervention LGA, of the 66 RDT-negative 
under-fives who did not receive the first-line recom-
mended ACTs, 23 (58%) received any anti-malarial, in 
comparison to 3/67 (4%) in the comparison LGA. When 
appropriate management of RDT-negative under-fives 
was defined by those who did not receive any anti-malar-
ial, prevalence of appropriate treatment was 37% in the 
intervention LGA and 93% in comparison areas. On 
adjustment for a priori confounders, the odds of appro-
priate management of RDT-negative under-fives who did 
not receive any anti-malarial were substantially lower 
among those children treated at intervention health facil-
ities (AOR 0.12; 95% CI 0.02, 0.77) (Table 5).
In both areas, a small number of RDT-positives (15 in 
intervention LGA and 7 in comparison LGA) were not 
given AL or ASAQ, and Fig. 1 shows that these children 
were given another anti-malarial, frequently artesu-
nate monotherapy or chloroquine. Overall 10% (95% CI 
3.8–25.7%) of febrile under-fives in intervention facili-
ties, and 14% (95% CI 5.1–33.5%) in comparison facilities 
were prescribed artesunate as monotherapy (p = 0.632). 
Among RDT-positives in both the intervention and 
comparison facilities, 10% were prescribed artesunate 
as monotherapy (p = 0.981). However, among RDT-
negatives, no under-fives were prescribed artesunate as 
monotherapy.
Discussion
The evaluation found there to be a higher prevalence of 
RDT testing in the health facilities in the intervention 
LGA (56% versus 36%), however this was not statistically 
significant. This finding is supported by similar results 
of training involving fever case management from pub-
lic health centres in Uganda [15], where 68.4% and 41.2% 
of children were tested in intervention versus control 
facilities adjusted risk ratio 1.66 (confidence interval 
0.88, 3.12; p = 0.11). In a synthesis of 10 studies (sites 
included Afghanistan 2; Cameroon 1; Ghana 1; Nigeria 1; 
Tanzania 2; and Uganda 3) on the impact of introducing 
malaria RDTs the ACT Consortium found the propor-
tion of patients tested with an RDT varied widely but that 
the largest increases in parasitological testing was where 
RDTs were introduced outside of health facilities [16].
Appropriate management of RDT-positive children 
aged under 5 years was high with 85% and 90% of RDT-
positive under-fives receiving AL or ASAQ in control and 
intervention LGAs respectively, with no statistical differ-
ence between them.
Appropriate management of RDT-negatives was high 
in both intervention and comparison LGAs when defined 
as not prescribing an ACT (AL/ASAQ). However, pre-
scription of non-ACT anti-malarials was a problem in 
intervention LGA health facilities. Based on including 
non-ACT anti-malarials in the definition of appropriate 
treatment, the health facilities in the comparison LGA 
performed better (37% appropriate treatment in inter-
vention versus 93% in comparison health facilities). This 
finding suggests a particularly high lack of confidence 
by health workers and/or by patients in negative RDT 
results in the intervention area. Lack of confidence in and 
adherence to negative RDT results has been well docu-
mented; in a systematic review including seven RCTs, 
prescribing of anti-malarials to RDT-negative patients 
was highly variable ranging from 0 to 81% [17]. Qualita-
tive studies have highlighted a range of potential reasons 
for non-adherence to negative RDT results including 
those relating to health workers lack of trust in the accu-
racy of the RDTs; worries on the outcome for the patient 
with a false negative result; lack of confidence on alterna-
tive actions if the fever is not due to malaria; and pressure 
to be prescribed an anti-malarial from patients [18, 19].
Adherence to appropriate treatment based on RDT 
results has been reported as relatively high in lower level 
cadres, such as community health workers [9]. Better 
adherence to treatment guidelines would, therefore, have 
been expected than was found. However, similar findings 
have been reported from Cameroon, where enhanced 
training effectively reduced inappropriate treatment of 
RDT-negative children with an anti-malarial from 84 to 
31% (RR 0.29, 0.11–0.77; p = 0.02), but basic training had 
no effect [20].
For an intervention to be successful and expected out-
comes to be achieved, the intervention itself needs to 
have been successfully implemented within a context 
conducive to its mechanisms leading to its outcomes. 
Findings on exposure to the malaria case management 
training intervention suggest that whilst all health facili-
ties were reached, only approximately half of health work-
ers within facilities were. This is an important limitation 
of cascade training. The intervention did not have an 
effect resulting in differential health worker behaviour in 
the intervention and comparison LGAs. There was more 
Page 8 of 11Jegede et al. Malar J           (2020) 19:90 
Ta
bl
e 
5 
M
al
ar
ia
 c
as
e 
m
an
ag
em
en
t o
ut
co
m
es
 b
y 
LG
A
a  
Ad
ju
st
ed
 fo
r: 
ch
ild
 c
ha
ra
ct
er
is
tic
s:
 a
ge
, s
ex
; c
ar
er
 c
ha
ra
ct
er
is
tic
s:
 e
du
ca
tio
n,
 s
ex
; h
ea
lth
 w
or
ke
r c
ha
ra
ct
er
is
tic
s:
 a
ge
, s
ex
; h
ea
lth
 fa
ci
lit
y 
da
ily
 re
co
rd
 s
to
ck
 a
va
ila
bi
lit
y 
ch
ar
ac
te
ris
tic
s:
 rd
t a
va
ila
bi
lit
y,
 e
ith
er
 A
L 
or
 A
SA
Q
 
av
ai
la
bi
lit
y
D
es
cr
ip
tiv
e 
re
su
lts
U
ni
va
ri
at
e 
re
su
lts
M
ul
tiv
ar
ia
te
  re
su
lts
a
In
te
rv
en
tio
n 
N
 = 
42
0
Co
m
pa
ri
so
n 
N
 = 
42
0
Ch
i2
 p
-v
al
ue
N
 
in
cl
ud
ed
 
in
 m
od
el
Cr
ud
e 
od
ds
 
ra
tio
Lo
w
er
 9
5%
 
CI
U
pp
er
 9
5%
 
CI
N
 
in
cl
ud
ed
 
m
od
el
A
dj
us
te
d 
od
ds
 
ra
tio
 a
Lo
w
er
 9
5%
 
CI
U
pp
er
 9
5%
 C
I
n
%
95
%
 C
I
N
%
95
%
 C
I
RD
T 
co
n-
du
ct
ed
25
3
55
.7
28
.2
, 8
0.
1
15
3
36
.4
16
.2
, 6
2.
9
0.
29
1
83
5
2.
21
0.
48
10
.0
7
82
3
1.
41
0.
30
, 6
.5
2
0.
 6
50
RD
T 
re
su
lt
N
 =
 2
53
N
 =
 1
53
0.
18
5
N
A
 P
os
iti
ve
16
9
65
.3
33
.9
, 8
7.
3
70
42
.2
23
.8
, 6
3.
1
 N
eg
at
iv
e
77
34
.7
12
.7
, 6
6.
1
72
57
.8
36
.9
, 7
6.
2
A
pp
ro
pr
ia
te
 m
an
ag
em
en
t o
f R
D
T 
po
si
tiv
e 
w
ith
 A
SA
Q
 o
r A
L
N
 =
 1
68
N
 =
 7
0
0.
55
4
 Y
es
15
3
90
.5
35
.0
, 8
4.
9
63
84
.7
60
.0
, 9
5.
3
23
8
1.
73
0.
25
11
.9
3
23
6
1.
91
0.
36
, 1
0.
04
0.
42
6
A
pp
ro
pr
ia
te
 m
an
ag
em
en
t o
f R
D
T 
ne
ga
tiv
e 
(d
id
 n
ot
 re
ce
iv
e 
A
SA
Q
 o
r A
L)
N
 =
 7
3
N
 =
 7
1
0.
20
4
 Y
es
66
88
.7
66
.5
, 9
6.
9
67
96
.2
82
.1
, 9
9.
3
14
4
0.
30
0.
04
2.
21
14
4
0.
68
0.
11
, 4
.3
6
0.
66
4
A
pp
ro
pr
ia
te
 m
an
ag
em
en
t o
f R
D
T 
ne
ga
tiv
e 
(d
id
 n
ot
 re
ce
iv
e 
an
y 
an
tim
al
ar
ia
l)
N
 =
 7
3
N
 =
 7
1
0.
00
4
 Y
es
43
37
.2
8.
9,
 7
8.
3
64
92
.7
68
.0
, 9
8.
7
14
4
0.
05
0.
00
5
0.
46
9
14
4
0.
12
0.
02
, 0
.7
7
0.
02
8
Page 9 of 11Jegede et al. Malar J           (2020) 19:90  
training in the intervention LGA, and more in compari-
son to baseline too but only 50% prevalence of exposure 
to training amongst health workers. It was not possible 
to analyse the performance of individual health work-
ers who reported having been trained compared with 
those not trained, as the question in the survey through 
which this analysis would be done (health worker id), was 
poorly completed. The lack of effect does not seem to be 
likely due to contamination, as IMCI and malaria training 
decreased in the health facilities in the comparison LGA 
and the two LGAs were selected as non-bordering.
This study provides an example of the difficulties of 
implementing an intervention into a routine health sys-
tem at scale. Cascade training is very commonly used by 
national programmes faced with the need for training on 
a large-scale, with limited financial and human resources. 
There are two major risks in cascade training: firstly of 
not reaching all of those needing training as in the cur-
rent study, and secondly, of quality decay as the training 
is passed down the cascade. Despite a dearth of evidence 
on the effectiveness of cascade training there are exam-
ples of successful models including that of well-super-
vised cascade-training including refresher workshops to 
scale-up mental health services in a demonstration pro-
ject in Nigeria [21]. Training needs to focus on not just 
initiating activities by health workers but on embedding 
these activities in their working day [22]. More imple-
mentation studies are needed on different models of 
cascade training in order to ensure their effectiveness and 
maximize their potential.
Limitations
The originally planned pre-post comparison study design 
was not possible due to policy change, requiring a change 
in definition of the outcome of appropriate treatment to 
include RDT testing, which was not available at baseline. 
The baseline survey was undertaken pre-policy change 
from presumptive treatment of febrile children with an 
ACT to parasitological diagnosis, with treatment based 
on this diagnosis. No record of RDT use in either LGA 
was taken during the baseline survey.
Conclusions
The study did not show a significant difference in the 
use of parasitological testing for malaria in febrile chil-
dren in intervention and comparison health facilities. 
The malaria case management intervention implemented 
through cascade training reached approximately half of 
health workers in a context of significant stock-outs of 
both ACT medicines and RDTs.
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